Lumenis Pulse™ 120H

MOSES Technology
The MOSES 2.0 Technology advances the next generation of Lithotripsy and BPH treatments by leveraging versatility, speed and power. ^1,6

Nearly 20% reduction in procedure time¹
As shown in a randomized clinical trial, the MOSES 2.0 Technology reduces procedure time by 20%, making your treatments faster and more efficient. ¹

50% reduction in retropulsion¹
The MOSES 2.0 Technology has taken retropulsion reduction to the next level, decreasing retropulsion levels by 50%.¹

33% reduction in fragmentation time¹
MOSES 2.0 Technology high precision and optimized impact on the target stone makes the most of every shot, leading to a greater ablation rate compared to regular pulses. ¹

MOSES Technology for BPH results in over 90% of patients being discharged on the same-day^8-10
With more efficient procedures and significantly reduced blood loss – MOSES 2.0 Technology for BPH results in over 90% of patients being discharged on the same day, and same-day catheter removal has been demonstrated with a 90% success rate*.^3,5,6

*In select patients

Energy transmission vs. working distance
Bench test* – A representative case²

Lumenis Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology

Risk Information:

The use of MOSES Technology in Urology, enabled in the Lumenis Pulse™ 120H system, is contraindicated for patients who are unable to receive endoscopic treatments or are intolerant to prolonged anesthesia, as well as for resection or excision of large vascularized organs. Holmium lasers are intended solely for use by physicians trained in the use of Ho:YAG (2.1 µm) wavelength. Incorrect treatment settings can cause serious tissue damage.The laser should be used only on tissues that are fully observable. See the system user manual for a complete list of contraindications and risks.